本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

79.31
+0.64500.82%
成交量:132.81万
成交额:1.04亿
市值:131.01亿
市盈率:-33.32
高:79.35
开:79.16
低:77.67
收:78.66
52周最高:86.74
52周最低:23.95
股本:1.65亿
流通股本:1.64亿
量比:0.62
换手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-2.3800
每股收益(LYR):-2.3812
净资产收益率:-70.80%
总资产收益率:-7.31%
市净率:26.79
市盈率(LYR):-33.30

数据加载中...

2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities